137793-96-5

Basic information

• Product Name: (1R,2R,3S,4R,5S)-3,4,5-tribenzyloxy-2-hydroxy-6-oxocyclohexyl acetate
• Synonyms: (1R,2R,3S,4R,5S)-3,4,5-tribenzyloxy-2-hydroxy-6-oxocyclohexyl acetate
• CAS NO: 137793-96-5
• Molecular Weight: 490.553
• Mol File: 137793-96-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (1R,2R,3S,4R,5S)-3,4,5-tribenzyloxy-2-hydroxy-6-oxocyclohexyl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,2R,3S,4R,5S)-3,4,5-tribenzyloxy-2-hydroxy-6-oxocyclohexyl acetate(137793-96-5)
• EPA Substance Registry System: (1R,2R,3S,4R,5S)-3,4,5-tribenzyloxy-2-hydroxy-6-oxocyclohexyl acetate(137793-96-5)

Safety Data

• Hazardous Substances Data: 137793-96-5(Hazardous Substances Data)

Upstream product

• 137793-90-9 (Z)-methyl 6-O-acetyl-2,3,4-tri-O-benzyl-α-D-gluco-hex-5-enopyranoside 
• 137793-91-0 (E)-methyl 6-O-acetyl-2,3,4-tri-O-benzyl-α-D-gluco-hex-5-enopyranoside 
• 53008-65-4 methyl 2,3,4-tri-O-benzyl-D-glucopyranoside 
• 83051-88-1 methyl 6-aldehydo-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 202798-31-0 C₃₀H₃₂O₇ 

Downstream Products

• 137793-99-8 1-O-acetyl-3,4,5-tri-O-benzyl-D-myo-inositol 
• 220198-32-3 D-3-O-acetyl-1,5,6-tri-O-benzyl-epi-inositol 
• 1185995-98-5 C₃₄H₃₈O₈ 
• 202845-40-7 1-((1S,2S,3S,4R,5S,6S)-2-Allyloxy-3,4,5,6-tetrakis-benzyloxy-cyclohexyloxymethyl)-4-methoxy-benzene 
• 202845-42-9 1-O-allyl-3,4,5-tri-O-benzyl-D-myo-inositol 
• 132437-54-8 1-O-allyl-2,3,4,5-tetra-O-benzyl-D-myo-inositol 
• 64681-28-3 D-1-O-allyl-3,4,5,6-tetra-O-benzyl-myo-inositol 
• 132437-55-9 1-O-allyl-2,3,4,5,6-penta-O-benzyl-D-myo-inositol 
• 342905-26-4 D-3-O-acetyl-epi-inositol 
• 190060-68-5 1,5,6-tri-O-benzyl-epi-inositol 
• 131233-69-7 3,4,5-tri-O-benzyl-D-myo-inositol 
• 576-63-6 cis-inositol 
• 488-58-4 epi-Inositol 
• 87-89-8 D-myo-inositol 

Relevant articles and documents

Efficient syntheses of chiral myo-inositol derivatives-key intermediates in glycosylphosphatidylinositol (GPI) syntheses

A facile and effective method was developed for large-scale syntheses of myo-inositol derivatives with the 1,2,6-O-positions differentiated from each other and from other positions as well. The syntheses started from methyl α-d-glucopyranoside, and the ke

Ready routes to key myo-inositol component of GPIs employing microbial arene oxidation or Ferrier reaction

Microbial arene oxidation or Ferrier reaction of enol acetates provides versatile complementary routes that greatly facilitate preparation of inositol synthon(s) for GPI assembly.

Biomimetic Synthesis of Enantiomerically Pure D-myo-Inositol Derivatives

-